Close Menu

NEW YORK – Telegenomics firm Genome Medical said Wednesday that it has raised $14 million in an extended Series B financing round, adding to the $23 million it raised in the Series B financing last year.

The San Francisco-headquartered company plans to use the funds to improve patient engagement and navigation within its Genome Care Delivery technology platform, so that more patients in the US have access to genomic medicine for cancer, reproductive health, and pharmacogenetics.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

New analyses indicate the P.1 variant found in Brazil may be able to infect people who have already had COVID-19, the New York Times reports.

According to CNBC, Novavax's CEO says its vaccine could be authorized in the US as early as May.

The US National Institutes of Health has a new initiative to address structural racism in biomedical research.

In PNAS this week: GWAS of TLV-1-associated myelopathy/tropical spastic paraparesis, analysis of twins with hypertrophic cardiomyopathy, and more.